3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Meningeal Carcinomatosis
1
Glioma
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
paclitaxel-Angiopep-2 conjugate
2
osimertinib
2
omburtamab I-131
2
AZD3759
2
eribulin
1
XL647
1
WP 744
1
Methotrexate
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Meningeal Carcinomatosis
×
WP 744
×
Clear all
NCT00527410
2025-05-30
LMD
Biogen
Phase 1
Terminated
9 enrolled